Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001
Symbol
SKYE on Nasdaq
Shares outstanding
33,945,050
Price per share
$0.96
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,131,666
Total reported value
$12,093,567
% of total 13F portfolios
0%
Share change
-3,751,499
Value change
-$11,627,173
Number of holders
49
Price from insider filings
$0.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
5AM Partners VII, LLC 34% -6.7% $15,119,125 -$203,807 11,541,317 -1.3% Andrew J. Schwab 12 Dec 2025
SPHERA FUNDS MANAGEMENT LTD. 4.8% $2,952,706 1,476,353 Sphera Funds Management Ltd. 31 Mar 2025
Schonfeld Strategic Advisors LLC 3.6% -32% $4,441,437 -$1,996,997 1,115,939 -31% Schonfeld Strategic Advisors LLC 30 Jun 2025

As of 31 Dec 2025, 49 institutional investors reported holding 16,131,666 shares of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE). This represents 48% of the company’s total 33,945,050 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) together control 47% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
5AM Venture Management, LLC 29% 9,681,763 0% 2.3% $7,258,418
Versant Venture Management, LLC 5.9% 2,007,704 0% 1% $1,505,176
BAKER BROS. ADVISORS LP 4.3% 1,450,638 0% 0.01% $1,087,543
VANGUARD GROUP INC 2.6% 882,785 0% 0% $662,089
SPHERA FUNDS MANAGEMENT LTD. 1.4% 478,928 0% 0.08% $359,052
MILLENNIUM MANAGEMENT LLC 1.1% 380,478 -5.4% 0% $285,244
BlackRock, Inc. 0.83% 281,841 +0.71% 0% $211,297
PLATINUM INVESTMENT MANAGEMENT LTD 0.69% 233,095 0% 0.04% $174,751
GEODE CAPITAL MANAGEMENT, LLC 0.62% 210,151 +0.74% 0% $157,603
Schonfeld Strategic Advisors LLC 0.28% 93,407 -92% 0% $70,025
STATE STREET CORP 0.22% 75,326 0% 0% $56,472
XTX Topco Ltd 0.16% 53,040 0% $39,764
TWO SIGMA INVESTMENTS, LP 0.15% 51,706 -44% 0% $38,764
TWO SIGMA ADVISERS, LP 0.12% 40,982 0% $30,724
HRT FINANCIAL LP 0.08% 27,348 0% $20,000
JANE STREET GROUP, LLC 0.07% 24,615 +93% 0% $18,453
Engineers Gate Manager LP 0.07% 23,138 0% $17,347
GSA CAPITAL PARTNERS LLP 0.07% 22,877 0% $17,000
BARCLAYS PLC 0.06% 21,251 0% $15,932
NORTHERN TRUST CORP 0.06% 20,142 -31% 0% $15,100
GROUP ONE TRADING LLC 0.05% 17,697 +634% 0% $13,267
R Squared Ltd 0.04% 14,782 0.01% $11,082
UBS Group AG 0.04% 13,286 -56% 0% $9,965
CAPITAL ADVISORS INC/OK 0.03% 10,000 0% 0% $7,497
SIMPLEX TRADING, LLC 0.02% 6,331 0% $4,746

Institutional Holders of Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 16,131,666 $12,093,567 -$11,627,173 $0.75 49
2025 Q3 19,883,163 $78,141,353 -$2,101,329 $3.93 56
2025 Q2 20,399,360 $85,269,369 -$12,432,557 $4.18 54
2025 Q1 24,700,100 $39,307,441 -$1,237,638 $1.59 72
2024 Q4 25,208,315 $71,310,457 -$3,219,919 $2.83 70
2024 Q3 25,729,728 $100,585,169 +$1,208,054 $3.91 72
2024 Q2 24,496,645 $196,252,371 +$179,861,577 $8.01 62
2024 Q1 2,009,303 $31,404,827 +$31,400,475 $15.64 3
2023 Q4 1,600 $4,352 $2.72 1